Jane Street’s Pear Therapeutics, Inc. Warrant PEARW Stock Holding History

Jane Street’s Portfolio PEARW Stock Details PEARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-19,557	Closed	-$374	–	10020
2023 Q1	$374	Hold	19,557	–	–	﹤0.01%	8899
2022 Q4	$2.91K	Buy	19,557 +327	+2%	+$52	﹤0.01%	8914
2022 Q3	$3K	Buy	19,230 +101	+0.5%	+$15	﹤0.01%	9505
2022 Q2	$2K	Sell	19,129 -1,213	-6%	-$599	﹤0.01%	9491
2022 Q1	$16K	Buy	20,342 +1,079	+6%	+$755	﹤0.01%	10003
2021 Q4	$12K	Buy	+19,263	New	+$19.6K	﹤0.01%	9890

Other funds holding PEARW

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Jane Street's PEARW Position: Q2 2023 in Review

Jane Street sold out of Pear Therapeutics, Inc. Warrant (PEARW) in Q2 2023, closing a stake of 19,557 shares — an estimated $374 sold.

Jane Street first reported a position in PEARW in Q4 2021 and held it in 6 quarters. The position peaked at $16K in Q1 2022. 2 funds tracked by Wall St. Rank hold PEARW as of Q2 2023.

Jane Street reported no remaining Pear Therapeutics, Inc. Warrant position as of Q2 2023 after selling out during the quarter.
Jane Street sold 19,557 Pear Therapeutics, Inc. Warrant shares in Q2 2023, an estimated $374.
Jane Street first reported a position in Pear Therapeutics, Inc. Warrant in Q4 2021 and held it in 6 quarters.
Jane Street's Pear Therapeutics, Inc. Warrant position peaked at $16K in Q1 2022.
2 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Warrant as of Q2 2023.

Based on Jane Street's 13F filing for Q2 2023, filed 14 Aug 2023.